Open AccessFirst‐Line Chemotherapy for Ovarian Cancer: Inferences From Recent Studies
Author(s) -
Rose Peter G.
Publication year - 2016
Publication title -
the oncologist
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.176
H-Index - 164
eISSN - 1549-490X
pISSN - 1083-7159
DOI - 10.1634/theoncologist.2016-0144
Subject(s) - medicine , taxane , ovarian cancer , oncology , chemotherapy , first line , standard of care , clinical trial , cancer , gynecology , breast cancer
This review discusses the evolution of platinum and taxane first‐line chemotherapy for ovarian cancer and the most recent trials and their impact on the current standard of care.